Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX

Goldman Sachs Group Inc reported a 6.50% stake in Syndax Pharmaceuticals, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 13, 2025

Goldman Sachs Group Inc reported a 6.50% stake in Syndax Pharmaceuticals, Inc., 5,581,828 shares, as a passive investor on Jun 30, 2025. Filed Aug 13, 2025 (Schedule 13G/A).

Stake
6.50%
Shares
5,581,828
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
THE GOLDMAN SACHS GROUP, INC.6.50%5,581,828
GOLDMAN SACHS & CO. LLC6.50%5,581,828

Source

View original at SEC

Related